Geode Capital Management, LLC Cocrystal Pharma, Inc. Transaction History

Geode Capital Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$0.38 - $0.55 $3,344 - $4,840	8,801 Added 1.1%	809,403 $331,000
Q3 2021 Nov 12, 2021	BUY	$1.01 - $1.25 $244,692 - $302,837	242,270 Added 43.39%	800,602 $840,000
Q2 2021 Aug 13, 2021	BUY	$1.08 - $2.14 $229,434 - $454,619	212,439 Added 61.42%	558,332 $697,000
Q1 2021 May 12, 2021	BUY	$1.3 - $2.35 $18,424 - $33,306	14,173 Added 4.27%	345,893 $480,000
Q4 2020 Feb 12, 2021	BUY	$0.8 - $2.16 $61,059 - $164,859	76,324 Added 29.88%	331,720 $451,000
Q3 2020 Nov 13, 2020	SELL	$0.86 - $2.36 $7,181 - $19,706	-8,350 Reduced 3.17%	255,396 $237,000
Q2 2020 Aug 13, 2020	BUY	$0.7 - $1.58 $155,310 - $350,557	221,872 Added 529.86%	263,746 $400,000
Q1 2020 May 14, 2020	BUY	$0.48 - $2.19 $20,099 - $91,704	41,874 New	41,874 $29,000

Ticker COCP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 8,122,420
Market Cap $21.3M
Description
Cocrystal Pharma, Inc., a biotechnology company, focuses on the discovery and development of antiviral therapeutic treatments for serious and/or chronic viral diseases. It employs structure-based technologies to create antiviral drugs primarily to treat hepatitis C virus (HCV), influenza virus, coronavirus, and norovirus infections. The company ...

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Geode Capital Management, LLC with notifications on news.